BSA Limited
BSA Limited (BSA.AX) Financial Performance & Income Statement Overview
Explore the financials of BSA Limited (BSA.AX), including yearly and quarterly data on income, cash flow, and balance sheets.
BSA Limited (BSA.AX) Income Statement & Financial Overview
Analyze BSA Limited’s BSA.AX earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $148.34M | $134.26M | $121.40M | $116.81M |
| Cost of Revenue | $126.74M | $114.64M | $104.78M | $102.64M |
| Gross Profit | $21.60M | $19.62M | $16.62M | $14.18M |
| Gross Profit Ratio | $0.15 | $0.15 | $0.14 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $2.92M | $5.36M | $8.04M | $6.35M |
| Operating Expenses | $2.92M | $5.36M | $8.04M | $6.35M |
| Total Costs & Expenses | $129.66M | $120.004M | $112.82M | $108.98M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $642000.00 | $644000.00 | $761000.00 | $1.04M |
| Depreciation & Amortization | $1.98M | -$444000.00 | $1.53M | $2.05M |
| EBITDA | $14.92M | $11.51M | $10.11M | $9.88M |
| EBITDA Ratio | $0.10 | $0.09 | $0.08 | $0.08 |
| Operating Income | $18.68M | $14.26M | $15.45M | $7.83M |
| Operating Income Ratio | $0.13 | $0.11 | $0.13 | $0.07 |
| Other Income/Expenses (Net) | -$7.24M | -$5.05M | -$761000.00 | -$1.04M |
| Income Before Tax | $11.45M | $9.21M | $7.81M | $6.79M |
| Income Before Tax Ratio | $0.08 | $0.07 | $0.06 | $0.06 |
| Income Tax Expense | $3.58M | -$1.95M | $89000.00 | $2.23M |
| Net Income | $7.87M | $8.58M | $2.05M | $6.45M |
| Net Income Ratio | $0.05 | $0.06 | $0.02 | $0.06 |
| EPS | $0.09 | $0.16 | $0.03 | $0.09 |
| Diluted EPS | $0.09 | $0.15 | $0.03 | $0.09 |
| Weighted Avg Shares Outstanding | $91.57M | $71.51M | $71.82M | $71.51M |
| Weighted Avg Shares Outstanding (Diluted) | $91.57M | $73.69M | $74.69M | $71.51M |
The company's financials show resilient growth, with revenue advancing from $116.81M in Q4 2023 to $148.34M in Q2 2025. Gross profit remained healthy with margins at 15% in Q2 2025 compared to 12% in Q4 2023. Operating income hit $18.68M last quarter, sustaining a consistent 13% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $14.92M. Net income dropped to $7.87M, while earnings per share reached $0.09. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan